medigraphic.com
ISSN 1560-4381 (Print)

2016, Number 3

<< Back Next >>

Correo Científico Médico 2016; 20 (3)

Modifiable risk factors in uncontrolled high blood pressure patients of Banjul, Gambia

Vega AJ, Garcés HY, Almaguer MLE, Vega CY

Language: English
References: 18
Page: 479-489
PDF size: 383.95 Kb.


ABSTRACT

Introduction: high blood pressure is a risk factor that could lead to cardiovascular disease and stroke.
Objective: to assess the prevalence and association of the modifiable risk factors with uncontrolled blood pressure among hypertensive patients in Medical Outpatient Department in "Edward Francis Small" Teaching Hospital, Banjul, The Gambia.
Methods: a cross-sectional survey was carried out during November 2013; the sample comprised 146 hypertensive patients, after receiving informed consent, hypertensive patients were interviewed about modifiable risk factors. Patients' blood pressure and body mass index were checked, the data was coded and processed using the Statistical Package for Social Sciences (version 15), a multiple logistic regression model was used to estimate the simultaneous effect of several determinants.
Results: the study showed that 52% of patients had uncontrolled blood pressure, 43.8% were overweight, 56.2% had unhealthy diet and 74.7% had physical inactivity, the predicted risk factors for uncontrolled high blood pressure, using univariate analysis were: unhealthy diet (p=0.000) and uncontrolled diabetes (p=0.007), the multivariate stepwise logistic regression analysis showed that for uncontrolled blood pressure the variables included as predictors: physical inactivity(p=0.793), overweight(p=0.631), unhealthy diet (p=0.170) and uncontrolled diabetes (p=0.28) were not significantly associated for uncontrolled blood pressure, the 78.9% of uncontrolled blood pressure had two or more modifiable risk factors, the number of modifiable risk factors were significantly associate with the control of blood pressure (Pearson χ2 = 22.667, p= 0.000).
Conclusions: the half of hypertensive patient were uncontrolled, the majority of patients had two or more modifiable risk factors.


REFERENCES

  1. Miniño AM, Murphy SL. Death in the United States, 2010. NCHS data brief.2012 [citado 3 mar 2016];99:1-8.Disponible en: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.259.8617&rep=rep1&type=pdf

  2. Narain JP. Integrating services for non-communicable diseases prevention and control: Use of primary health care approach. Indian J Community Med. 2011[citado 12 ene 2015]; 36(Suppl1): 67-71. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354898/.

  3. Centers for Disease Control and Prevention (CDC). Million hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors--United States, 2011. MMWR Morb Mortal Wkly Rep. 2011[citado 1 mar 2016]; 60(36): 1248-1251. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21918495.

  4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL , et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003[citado 10 jun 2010]; 42(6):1206–1252. Disponible en: https://hyper.ahajournals.org/content/42/6/1206.full

  5. WHO. Global status report on noncommunicable diseases 2014. Geneva: WHO; 2014 [citado 11 jun 2015]. Disponible en: http://www.who.int/nmh/publications/ncd-status-report-2014/en/

  6. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care. The Framingham Heart Study. Circulation. 2008 [cited 2010 Jan 10]; 117(6):743-753. Disponible en: http://circ.ahajournals.org/cgi/content/full/117/6/743

  7. Fuchs FD, Costa Fuchs S, Beltrami Moreira L, Gus M. Proof of concept in cardiovascular risk: the paradoxical findings in blood pressure and lipid abnormalities. Vasc Health Risk Manag. 2012[citado 12 jun 2015]; 8: 437–442. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411330/pdf/vhrm-8-437.pdf

  8. Hutcheson R, Rocic P. The Metabolic Syndrome, Oxidative Stress, Environment, and Cardiovascular Disease: The Great Exploration. Exp Diabetes Res. 2012[citado 15 jun 2015]; 2012:271028.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399393/

  9. WHO. Global recommendations on physical activity for health. Geneva: WHO;2010 [citado 15 jun 2015]. Disponible en: http://apps.who.int/iris/bitstream/10665/44399/1/9789241599979_eng.pdf

  10. WHO. Diet, nutrition and the prevention of chronic diseases. Report of a Joint WHO/FAO Expert Consultation. Geneva: WHO;2003 [citado 15 jun 2015].Disponible en: http://www.who.int/dietphysicalactivity/publications/trs916/en/gsfao_introduction.pdf

  11. 11.WHO. Effect of reduced sodium intake on blood pressure, renal function, blood lipids and other potential adverse effects. Geneva: WHO; 2012[citado 15 jun 2012]. Disponible en: http://apps.who.int/iris/bitstream/10665/79325/1/9789241504911_eng.pdf

  12. Charakida M, Masi S, Deanfield JE. The Year in Cardiology 2012: focus on cardiovascular disease prevention. Eur Heart J.2013 [citado 13 jun 2015]; 34(4): 314–317. Disponible en: http://eurheartj.oxfordjournals.org/content/ehj/early/2013/01/02/eurheartj.ehs429.full.pdf

  13. Tarragó E, Miguel Soca PE, Cruz L, Santiesteban Y. Factores de riesgo y prevención de la cardiopatía isquémica. CCM. 2012 [citado 20 nov 2013]; 16(2). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/505

  14. Vega J, Guimará M, Vega L. Cardiovascular risk, a useful tool for prevention of cardiovascular diseases. Rev Cubana Med Gen Integr. 2011[citado 13 dic 2015];27(1):91-7. Disponible en: http://scielo.sld.cu/pdf/mgi/v27n1/mgi10111.pdf

  15. WHO. Implementation tools: package of essential non communicable (PEN) disease interventions for primary health care in low-resource settings. Geneva: WHO;2013. [citado 5 nov 2013]. Disponible en: http://www.who.int/cardiovascular_diseases/publications/implementation_tools_WHO_PEN/en/.

  16. Nordet P, Mendis M, Dueñas A, de la Noval R, Armas N, de la Noval IL ,et al. Total cardiovascular risk assessment and management using two prediction tools, with and without blood cholesterol. MEDICC Rev. 2013 [citado 26 nov 201];15(4):36-40. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24253349

  17. Vega J, Guimara M, Garces Y, Garcia Y, Vega L. High sensitivity c reactive protein and cardiovascular disease risk. CCM.2015 [citado 27 nov 2015];19(2):190-201. Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/download/978/620

  18. Vega J, Guimara M, Garces Y, Vega L, Rivas M. Prediction of coronary and cardiovascular global risk in primary health care. CCM.2015 [citado 27 nov 2015];19(2):202-211. Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/download/979/622




2020     |     www.medigraphic.com